CannabisNewsBreaks – The Flowr Corp. Partners with Scotts Miracle-Gro Company (NYSE: SMG) Subsidiary to Conduct Cannabis Testing

August 27, 2018 09:40:20

The Flowr Corp., a Canadian licensed producer that focuses primarily on premium flower production, was recently highlighted in a Bloomberg article titled, “Scotts Miracle-Gro Tests Whether It Can Make Pot Grow Too,” authored by Kristine Owram. Per the article, Scotts Miracle-Gro Company’s (NYSE: SMG) subsidiary, Hawthorne Gardening Co., is partnering up with Flowr to build a 50,000-square-foot research facility on the same site as Flowr’s grow-op in Kelowna, British Columbia. Firstly, the new lab will test Hawthorne’s lights and nutrients on cannabis, with plans to ultimately conduct more in-depth studies on the plant.

Currently producing 250 grams a square foot at its grow-op, Flowr seeks to nearly double that number to produce some of the highest crop yields in the industry, targeting an ultimate yield of 450 grams. The company has already inked supply agreements with the Ontario and B.C. governments ahead of legalization and has secured a distribution agreement to sell medical marijuana in Germany next year. Presently, the company’s seasoned executives are eyeing opportunities in the Caribbean and South America. The president and co-founder of Flowr, Tom Flow, was also the co-founder of MedReleaf Corp., a company recently acquired by Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) for roughly $2.2 billion in stock. Flow also brought several of the MedReleaf team members to Flowr, which is set to list on the TSX Venture Exchange next month via a reverse takeover.

To view the full article, visit

About The Flowr Corp.

The Flowr Group (Okanagan) Inc., through its subsidiaries, is a vertically-integrated Canadian cannabis company focused on the natural science of cannabis. With head offices in Markham, ON and production in Kelowna, BC, Flowr builds and operates large-scale, GMP compliant cultivation facilities utilizing its own patented growing systems. Flowr’s investment in research and development ensures that its master growers are able to supply patients with consistent, high-quality medicinal cannabis. With a sense of craftsmanship and a spirit of innovation, Flowr is also well positioned with a line of premium quality cannabis products for the upcoming adult-use market. Flowr recently signed a Memorandum of Understanding to supply premium cannabis to the British Columbia Liquor Distribution Board which will be the sole retailer of non-medicinal cannabis in the province following the October 17 legalization of adult recreational consumption. The company announced earlier in the year that it had been selected by the Hawthorne Canada subsidiary of The Scotts Miracle-Gro Company for an exclusive strategic R&D alliance. Flowr also has announced its intention to list shares on the TSX Ventures Exchange. For more information, visit the company’s website at

More from CannabisNewsBreaks

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office